President Joe Biden's Department of Health and Human Services (HHS) has stopped following the Trump administration's policy that required community health centers to lower prescription drug prices, including epinephrine and insulin.
HHS released a statement on Friday entitled "Implementation of Executive Order on Access to Affordable Life-saving Medications," which said the previous administration's policies will be "delayed until March 22, 2021." HHS called the 60-day pause a "Regulatory Freeze Pending Review."
Trump signed four executive orders directed at the HHS in July including one that required, "federally qualified health centers that purchase insulins and epinephrine in the 340B program to pass the savings from discounted drug prices directly on to medically underserved patients."
The orders also sought to guarantee seniors paid no more for the most expensive Medicare Part B drugs than other comparable countries.